SNDX Syndax Pharmaceuticals, Inc.
Healthcare$19.90-0.20%ClosedMarket Cap: $1.76B
As of 2026-05-26
Insider Statistics (Q1 2026)
Acquisitions
16
Dispositions
4
Buy/Sell Ratio
4.00
Net Shares
+1,171,706
Shares Acquired
1,201,769
Shares Disposed
30,063
Total Bought ($)
$0.00
Total Sold ($)
$4.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Tue Feb 10 | Metzger Michael A | director, officer: Chief Executive Officer | Sell | 17,159 | $21.03 | 491,690 |
| Tue Feb 10 | Goldan Keith A. | officer: Chief Financial Officer | Sell | 3,410 | $21.03 | 140,429 |
| Fri Feb 06 | Metzger Michael A | director, officer: Chief Executive Officer | Sell | 7,412 | $20.62 | 508,849 |
| Fri Feb 06 | Metzger Michael A | director, officer: Chief Executive Officer | Sell | 440,000 | $20.43 | 440,000 |
| Fri Feb 06 | Metzger Michael A | director, officer: Chief Executive Officer | Sell | 144,600 | $0.00 | 516,261 |
| Fri Feb 06 | Metzger Michael A | director, officer: Chief Executive Officer | Sell | 73,000 | $0.00 | 371,661 |
| Fri Feb 06 | Goldan Keith A. | officer: Chief Financial Officer | Sell | 2,082 | $20.62 | 143,839 |
| Fri Feb 06 | Goldan Keith A. | officer: Chief Financial Officer | Sell | 118,000 | $20.43 | 118,000 |
| Fri Feb 06 | Goldan Keith A. | officer: Chief Financial Officer | Sell | 30,750 | $0.00 | 145,921 |
| Fri Feb 06 | Goldan Keith A. | officer: Chief Financial Officer | Sell | 21,500 | $0.00 | 115,171 |